Search Tag: cardiovascular research

2024 28 May

  Non-alcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction-associated steatotic liver disease (MASLD), affects over half of the global type 2 diabetes population and is a risk factor for cardiac remodelling and heart failure. The link between hepatic fibrosis in NAFLD and increased mortality in acute heart failure, as well...Read more